Cargando…

A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: A Dual-Acting Weapon for Targeting DNA in Cancer Cells

In this study, two DNA-targeting agents, cisplatin and chlorambucil, were combined in a Pt(IV) prodrug, 1, which was thoroughly characterized by means of spectroscopic and spectrometric techniques. Tested towards a panel of various human tumor cell lines, this compound showed superior in vitro antit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montagner, Diego, Tolan, Dina, Andriollo, Emma, Gandin, Valentina, Marzano, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321036/ https://www.ncbi.nlm.nih.gov/pubmed/30486477 http://dx.doi.org/10.3390/ijms19123775

Ejemplares similares

Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position
por: Tolan, Dina, et al.
Publicado: (2016)

Potent Chlorambucil-Platinum(IV) Prodrugs
por: Aputen, Angelico D., et al.
Publicado: (2022)

Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration
por: Barbanente, Alessandra, et al.
Publicado: (2022)

Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions
por: Savino, Salvatore, et al.
Publicado: (2018)

Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
por: Raveendran, Raji, et al.
Publicado: (2016)

Pt(IV) Prodrugs with NSAIDs as Axial Ligands
por: Spector, Daniil, et al.
Publicado: (2021)

Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
por: Petruzzella, Emanuele, et al.
Publicado: (2018)

Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake?
por: Ravera, Mauro, et al.
Publicado: (2021)

Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
por: Li, Xuejiao, et al.
Publicado: (2018)

Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs
por: Spector, Daniil, et al.
Publicado: (2022)

Encapsulation of Pt(iv) prodrugs within a Pt(ii) cage for drug delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2015)

Redox-Responsive Heparin–Chlorambucil Conjugate Polymeric Prodrug for Improved Anti-Tumor Activity
por: Andrgie, Abegaz Tizazu, et al.
Publicado: (2019)

Facile Synthesis of a Pt(IV) Prodrug of Cisplatin and Its Intrinsically (195m)Pt Labeled Analog: A Step Closer to Cancer Theranostic
por: Sharma, K. Shitaljit, et al.
Publicado: (2021)

Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance
por: Papadia, Paride, et al.
Publicado: (2020)

Riboflavin as a bioorthogonal photocatalyst for the activation of a Pt(IV) prodrug
por: Alonso-de Castro, Silvia, et al.
Publicado: (2017)

An intramolecular photoswitch can significantly promote photoactivation of Pt(iv) prodrugs
por: Deng, Zhiqin, et al.
Publicado: (2021)

Biological activity of Pt(IV) prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis
por: Alonso-de Castro, Silvia, et al.
Publicado: (2018)

Image-Guided Nanodelivery of Pt(IV) Prodrugs to GRP-Receptor Positive Tumors
por: Silva, Francisco, et al.
Publicado: (2023)

Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma
por: Moynihan, Eoin, et al.
Publicado: (2021)

pH-triggered dynamic erosive small molecule chlorambucil nano-prodrugs mediate robust oral chemotherapy
por: Liu, Xin, et al.
Publicado: (2023)

Novel Biotinylated Cu(II)-Phenanthroline Complexes: 2D and 3D Cytotoxic Activity and Mechanistic Insight
por: Barrett, Stephen, et al.
Publicado: (2023)

Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2014)

Photopolymerized 3D Printing Scaffolds with Pt(IV) Prodrug Initiator for Postsurgical Tumor Treatment
por: Zhang, Qingfei, et al.
Publicado: (2022)

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
por: Kastner, Alexander, et al.
Publicado: (2023)

Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment
por: Mao, Xiaoman, et al.
Publicado: (2022)

Pt(IV) prodrug initiated microparticles from microfluidics for tumor chemo-, photothermal and photodynamic combination therapy
por: Zhang, Qingfei, et al.
Publicado: (2022)

Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma
por: Moynihan, Eoin, et al.
Publicado: (2023)

Honokiol-Chlorambucil Co-Prodrugs Selectively Enhance the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo
por: Xia, Li, et al.
Publicado: (2020)

Structure elucidation and quantification of the reduction products of anticancer Pt(iv) prodrugs by electrochemistry/mass spectrometry (EC-MS)
por: Frensemeier, L. M., et al.
Publicado: (2018)

Chlorambucil-Induced Acute Interstitial Pneumonitis
por: Shafqat, Hammad, et al.
Publicado: (2014)

Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma
por: Liu, Yang, et al.
Publicado: (2019)

Chlorambucil-induced psoriasis: A rare entity
por: Kumar, Sumir, et al.
Publicado: (2020)

The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH(3)COO)Cl(2)(NH(3))(2)(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake
por: Gabano, Elisabetta, et al.
Publicado: (2022)

A pH-responsive liposomal nanoplatform for co-delivery of a Pt(IV) prodrug and cinnamaldehyde for effective tumor therapy
por: Tang, Ting, et al.
Publicado: (2023)

Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy
por: Du, Min, et al.
Publicado: (2022)

Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates
por: Novohradsky, Vojtech, et al.
Publicado: (2017)

Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines
por: Barth, Marie-Christin, et al.
Publicado: (2023)

Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N(3))(2)(OH)(2)(py)(2)], a Pt(IV) Diazido Anticancer Prodrug Candidate
por: Vernooij, Robbin R., et al.
Publicado: (2016)

Cellular Toxicity Mechanisms and the Role of Autophagy in Pt(IV) Prodrug-Loaded Ultrasmall Iron Oxide Nanoparticles Used for Enhanced Drug Delivery
por: Gutiérrez-Romero, L., et al.
Publicado: (2021)

Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy
por: Fu, Yuanlei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oghes44q5glgd0nqkkp7hjfo86